Impact of Genetic Variation in Breast Cancer Resistance Protein (BCRP/ABCG2) on Sunitinib Pharmacokinetics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of Genetic Variation in Breast Cancer Resistance Protein (BCRP/ABCG2) on Sunitinib Pharmacokinetics

Published:2012 Issue:6 Volume:27 Page:631-639
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Mizuno Tomoyuki,Fukudo Masahide,Terada Tomohiro,Kamba Tomomi,Nakamura Eijiro,Ogawa Osamu,Inui Ken-ichi,Katsura Toshiya

Publisher

Japanese Society for the Study of Xenobiotics

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference42 articles.

1. Sunitinib: from rational design to clinical efficacy;Chow;J. Clin. Oncol.,2007

2. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N. Engl. J. Med.,2007

3. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma;Motzer;J. Clin. Oncol.,2009

4. A phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma: Insights into the treatment, efficacy and safety;Uemura;Jpn. J. Clin. Oncol.,2010

5. Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea;Hong;Cancer Res. Treat.,2009

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the contribution of genetic variants to high sunitinib exposure in patients with cancer;British Journal of Clinical Pharmacology;2024-08-06

2. Management of high-alert medications by clinical pharmacological approaches;Folia Pharmacologica Japonica;2024-03-01

3. Pharmacogenomics of Cancer Chemotherapy: Transporter Polymorphisms and Drug Response;Interdisciplinary Cancer Research;2024

4. In vitro identification of decreased function phenotype ABCG2 variants;European Journal of Pharmaceutical Sciences;2023-09

5. Novel inhibitors of breast cancer resistance protein (BCRP, ABCG2) among marketed drugs;European Journal of Pharmaceutical Sciences;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3